From top to bottom, Kevin D. Hall, Yasmine Belkaid, David Leopold, John Tisdale (All photos courtesy of NIH)
Please Note: This program has a newly rescheduled date (originally January 15 and later January 24, 2019).
The National Institutes of Health (NIH) is the U.S. government’s medical research agency and the largest public funder of biomedical research in the world. NIH invests more than $30 billion of taxpayer dollars to support cutting-edge research that is helping people live longer and healthier lives, driving the discovery of new ideas, and combating major health challenges. NIH has the pulse on modern medicine.
The four-part series provides a unique opportunity to bring the efforts of NIH into public view. Join NIH scientific and medical experts to learn about what is currently “hot” in biomedical research and discuss what it all means for our health and medical treatment today and in the future.
Topics such as metabolism, the brain, an diet; the role of microbiota in immunity to infection; brain activity and visual perception; and gene therapies for sickle cell anemia will be discussed.
John Tisdale, Chief, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute
Tisdale discusses sickle cell disease, which affects 100,000 Americans and millions around the world. The inherited disease affects the hemoglobin in red blood cells that carries oxygen and results in severe anemia, frequent severe pain, organ damage, and early mortality. Because the abnormal red blood cells derive from bone marrow stem cells, he explains, efforts to cure the disease are focused on strategies to replace or repair bone marrow stem cells.
If you are interested in other sessions or viewing the full series, click here.
The National Institutes of Health (NIH) does not receive any revenue from this program series.